Factors Influencing Concordance Between Clinical and Ultrasound Findings in Rheumatoid Arthritis

Objective. Clinical joint examination (CJE) is less time-consuming than ultrasound (US) in rheumatoid arthritis (RA). Low concordance between CJE and US would indicate that the 2 tests provide different types of information. Knowledge of factors associated with CJE/US concordance would help to select patients and joints for US. Our objective was to identify factors associated with CJE/US concordance. Methods. Seventy-six patients with RA requiring tumor necrosis factor-α (TNF-α) antagonist therapy were included in a prospective, multicenter cohort. In each patient, 38 joints were evaluated. Synovitis was scored using CJE, B-mode US (B-US), and power Doppler US (PDUS). Joints whose kappa coefficient (κ) for agreement CJE/US was < 0.1 were considered discordant. Multivariate analysis was performed to identify factors independently associated with CJE/US concordance, defined as factors yielding p < 0.05 and OR > 2. Results. Concordance before TNF-α antagonist therapy varied across joints for CJE/US (κ = −0.08 to 0.51) and B-US/PDUS (κ = 0.30 to 0.67). CJE/US concordance was low at the metatarsophalangeal joints and shoulders (κ < 0.1). Before TNF-α antagonist therapy, a low 28-joint Disease Activity Score (DAS28) was associated with good CJE/B-US concordance, and no factors were associated with CJE/PDUS concordance. After TNF-α antagonist therapy, only the joint site was associated with CJE/B-US concordance; joint site and short disease duration were associated with CJE/PDUS concordance. Conclusion. Concordance between CJE and US is poor overall. US adds information to CJE, most notably at the metatarsophalangeal joints and shoulders. Usefulness is decreased for B-US when DAS28 is low and for PDUS when disease duration is short.

[1]  M. Dougados,et al.  The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound , 2012, Annals of the rheumatic diseases.

[2]  E. Naredo,et al.  A Systematic Literature Review Analysis of Ultrasound Joint Count and Scoring Systems to Assess Synovitis in Rheumatoid Arthritis According to the OMERACT Filter , 2011, The Journal of Rheumatology.

[3]  T. Kvien,et al.  Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis , 2011, Arthritis research & therapy.

[4]  A. Iagnocco,et al.  Validity of ultrasonography and measures of adult shoulder function and reliability of ultrasonography in detecting shoulder synovitis in patients with rheumatoid arthritis using magnetic resonance imaging as a gold standard , 2010, Arthritis care & research.

[5]  M. Dougados,et al.  Reproducibility of Joint Swelling Assessment by Sonography in Patients with Long-lasting Rheumatoid Arthritis (SEA-Repro Study Part II) , 2010, The Journal of Rheumatology.

[6]  M. Dougados,et al.  Reproducibility of Joint Swelling Assessments in Long-lasting Rheumatoid Arthritis: Influence on Disease Activity Score-28 Values (SEA-Repro Study Part I) , 2010, The Journal of Rheumatology.

[7]  Andrew K. Brown,et al.  Using ultrasonography to facilitate best practice in diagnosis and management of RA , 2009, Nature Reviews Rheumatology.

[8]  G. Burmester,et al.  Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. , 2009, Arthritis and rheumatism.

[9]  M. Dougados,et al.  Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[10]  R. Caporali,et al.  Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. , 2009, Rheumatology.

[11]  P. Emery,et al.  Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study. , 2009, Arthritis and rheumatism.

[12]  C. Peterfy,et al.  An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[13]  E. Naredo,et al.  Validity, reproducibility, and responsiveness of a twelve-joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[14]  R. Luukkainen,et al.  Poor relationship between joint swelling detected on physical examination and effusion diagnosed by ultrasonography in glenohumeral joints in patients with rheumatoid arthritis , 2007, Clinical Rheumatology.

[15]  A. Iagnocco,et al.  The OMERACT Ultrasound Group: status of current activities and research directions. , 2007, The Journal of rheumatology.

[16]  A. Iagnocco,et al.  Summary findings of a systematic review of the ultrasound assessment of synovitis. , 2007, The Journal of rheumatology.

[17]  C. Peterfy,et al.  Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. , 2006, Arthritis and rheumatism.

[18]  A. Iagnocco,et al.  Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab , 2006, Annals of the rheumatic diseases.

[19]  Franz Kainberger,et al.  Musculoskeletal ultrasound including definitions for ultrasonographic pathology. , 2005, The Journal of rheumatology.

[20]  E. Naredo,et al.  Ultrasonographic assessment of inflammatory activity in rheumatoid arthritis: comparison of extended versus reduced joint evaluation. , 2005, Clinical and experimental rheumatology.

[21]  H. Huhtala,et al.  Relationship between clinically detected joint swelling and effusion diagnosed by ultrasonography in elbow joints in patients with rheumatoid arthritis , 2005, Clinical Rheumatology.

[22]  A. Piccoli,et al.  Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept , 2004, Annals of the rheumatic diseases.

[23]  J Uson,et al.  Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography , 2004, Annals of the rheumatic diseases.

[24]  E. Gromnica-ihle,et al.  Standard reference values for musculoskeletal ultrasonography , 2004, Annals of the rheumatic diseases.

[25]  H. Thomsen,et al.  Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. , 2004, Arthritis and rheumatism.

[26]  D. Cosgrove,et al.  Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[27]  Michael J. Green,et al.  Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease , 2004, Annals of the rheumatic diseases.

[28]  P. Emery,et al.  Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination. , 2004, Arthritis and rheumatism.

[29]  M. Malaise,et al.  Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. , 2003, Radiology.

[30]  H. Huhtala,et al.  Relationship between clinically detected joint swelling and effusion diagnosed by ultrasonography in metatarsophalangeal and talocrural joints in patients with rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[31]  D. Kane,et al.  Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[32]  Marcin Szkudlarek,et al.  Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[33]  D Loreck,et al.  Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints , 2002, Annals of the rheumatic diseases.

[34]  C. Kneitz,et al.  High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor α receptor (etanercept) , 2002 .

[35]  M. Østergaard,et al.  Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. , 2001, Arthritis and rheumatism.

[36]  M. Østergaard,et al.  Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset , 2001, Annals of the rheumatic diseases.

[37]  H. Tony,et al.  Evaluation of pannus and vascularization of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis by high-resolution ultrasound (multidimensional linear array). , 1999, Arthritis and rheumatism.

[38]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[39]  M. Tanguy,et al.  Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. , 2012, Arthritis and rheumatism.

[40]  A. Iagnocco,et al.  Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis. , 2008, The Journal of rheumatology.

[41]  E. Naredo,et al.  Inter-observer agreement of standard joint counts in early rheumatoid arthritis: a comparison with grey scale ultrasonography--a preliminary study. , 2008, Rheumatology.

[42]  D. Cosgrove,et al.  Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[43]  C. Kneitz,et al.  High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor alpha receptor (etanercept). , 2002, Annals of the rheumatic diseases.